Sushil Selvarajan

14PUBLICATIONS
37CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Infant and child healthCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 27, 2026
Efficacy of Standard-Dose Versus Low-Dose Nivolumab in Relapsed/Refractory Hodgkin Lymphoma-A Retrospective Analysis.

Chirag Trivedi, Junita John, Sujith Karumathil

|Dec 31, 2025
Real world outcomes with the use of Inotuzumab Ozogamicin in relapsed/refractory B cell acute lymphoblastic leukemia.

Archita Ravindranath, Vijay Pandit, Uday Kulkarni

|Mar 15, 2025
Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience from hematology cancer consortium.

Akhil Rajendra, Manju Sengar, Anu Korula

|Feb 12, 2025
Therapeutic Versus Non-Therapeutic Dose Anticoagulation in COVID-19 Infection: A Systematic Review and Meta-analysis of Randomised Controlled Trials.

Sushil Selvarajan, Jisha Sara John, Prathap Tharyan

|Oct 27, 2024
Fungal Intracranial Infections (Central Nervous System-Invasive Fungal Disease) in Patients With Haematological Disorders-A Single-Centre Retrospective Study.

Sohini Chattopadhyay, Lydia Jennifer Sumanth, Harshad Arvind Vanjare

|Jul 16, 2024
Improving Outcomes with Haploidentical Stem Cell Transplantation [HaploSCT] in Children Using Post-transplant Cyclophosphamide: a Single Center Experience.

Biju George, Uday Kulkarni, Sharon Lionel

Pageof 3

Frequent Collaborators

11 joint publications

Uday Prakash Kulkarni

10 joint publications

Vikram Mathews

9 joint publications

Biju George

5 joint publications

Anu Korula